Come up with a name for your new list and we'll add to it:
Beta-Cell raised a round of funding on , . Investors include
Life Sciences Research Partners.
Beta-Cell is a privately owned biopharmaceutical company that develops novel cell therapies and other products related to Diabetes. Beta-Cell's lead product, BetaGraft1.0, is a novel cell replacement…